Pages that link to "Q44533290"
Jump to navigation
Jump to search
The following pages link to Isolation and structure of hypothalamic MSH release-inhibition hormone (Q44533290):
Displaying 50 items.
- Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide (Q28317232) (← links)
- Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats (Q28372327) (← links)
- Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin (Q33990974) (← links)
- Proline specific endo- and exopeptidases (Q34274964) (← links)
- Theoretical studies on pro-leu-gly-nh2 conformation (Q34997060) (← links)
- Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia (Q35092732) (← links)
- Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease (Q35927105) (← links)
- Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease (Q35959738) (← links)
- The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study (Q36128149) (← links)
- Search of the human proteome for endomorphin-1 and endomorphin-2 precursor proteins. (Q36282529) (← links)
- Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring (Q36464840) (← links)
- Concepts for biologically active peptides (Q36503835) (← links)
- Laser raman studies on the conformation of Pro-Leu-Gly-NH2 (Q36587562) (← links)
- Hypothalamic regulatory hormones: a review (Q36659203) (← links)
- Regulation of melanophore stimulating hormone (MSH) release (Q36991982) (← links)
- Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice (Q37313196) (← links)
- Tertiary Structure of H-Pro-Leu-Gly-NH 2 , the Factor That Inhibits Release of Melanocyte Stimulating Hormone, Derived by Conformational Energy Calculations (Q37437587) (← links)
- Hypothalamic Control of the Secretion of Melanocyte-Stimulating Hormone (MSH) and Adrenocorticotropin (ACTH) (Q37603986) (← links)
- A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors (Q39089026) (← links)
- Neurologically active peptides (Q39133371) (← links)
- Chemistry of natural and synthetic hypothalamic hormones (Q39145875) (← links)
- Correlation between the X-ray structure of melanostatin and its conformation in solution (Q39152663) (← links)
- The effect of somatostatin and of prolyl-leucyl-glycinamide (MIF) on ACTH release in dispersed pituitary cells (Q39165924) (← links)
- Peripheral administration of hypothalamic peptides results in CNS changes (Q39205982) (← links)
- Isolation and Characterization of Hypothalamic Peptide Hormones (Q39208006) (← links)
- Nuclear-Magnetic-Resonance Study of Aggregations and Conformations of Melanostatin and Related Peptides (Q39217951) (← links)
- The purification of a bovine kidney enzyme which cleaves melanocyte-stimulating hormone-release inhibiting factor (Q39221342) (← links)
- CNS effects of peripherally administered brain peptides (Q39270704) (← links)
- Somatostatin: Abundance of Immunoreactive Hormone in Rat Stomach and Pancreas (Q39373890) (← links)
- Peptides of the Central Nervous System (Q39590918) (← links)
- Platelet adhesion and aggregation in diabetes mellitus (Q39724325) (← links)
- Neurohypophyseal principles and memory processes (Q39776241) (← links)
- Chemistry of hypothalamic releasing factors (Q39880820) (← links)
- Hypothalamic regulatory hormones (Q39897025) (← links)
- The pituitary melanotrophic hormones (Q39902974) (← links)
- The Hypothalamus: Physiology and Clinical Use of Releasing Factors (Q39912990) (← links)
- Degeneration and regeneration of neurosecretory systems (Q39934184) (← links)
- Behavioral effects of melanocyte stimulating hormone release-inhibiting factor-1 (MIF-1) (Q40090870) (← links)
- Neurohypophyseal hormones and brain neurochemistry (Q40093880) (← links)
- 1H Nuclear magnetic resonance studies of melanostatin: Dependence of the chemical shifts of NH protons on temperature and concentration (Q40342712) (← links)
- Progress in understanding and treating Parkinson's disease. (Q40516246) (← links)
- Novel concepts from novel peptides (Q40577711) (← links)
- MSH-release inhibiting factors: recent studies (Q41446868) (← links)
- Effects of morphine and β-endorphin on basal and elevated plasma levels of α-MSH and vasopressin (Q41579855) (← links)
- Control of the pars intermedia of the lizard, Anolis carolinensis. III. Changes in the ultrastructure of the disconnected neuro-intermediate lobe (Q41730155) (← links)
- Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor (Q42218272) (← links)
- Control of the pars intermedia of the lizard, Anolis carolinensis. I. Ultrastructure of the intact neural lobe (Q42441489) (← links)
- α-MSH, MIF-I and melatonin: Effects on novelty-induced defecation, plasma 11-OHCS and central catecholamines in rats (Q43322813) (← links)
- Oxytocin Involvement in Male and Female Sexual Behavior (Q43794304) (← links)
- Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity (Q43828461) (← links)